We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Hypnosis on Motor Cortex Excitability

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00416247
First Posted: December 27, 2006
Last Update Posted: August 5, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Rambam Health Care Campus
  Purpose
This study is intended to investigate neurophysiological mechanisms of hypnosis using transcranial magnetic stimulation (TMS) and assessment of motor cortex excitability in healthy volunteers under hypnosis.

Condition Intervention
Healthy Behavioral: Hypnosis

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Effect of Hypnosis on Motor Cortex Excitability

Further study details as provided by Rambam Health Care Campus:

Primary Outcome Measures:
  • Cortical Excitability [ Time Frame: Before and after intervention ]

Enrollment: 20
Study Start Date: December 2006
Study Completion Date: June 2009
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Hypnosis
    Hypnosis
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 45 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria: .

  1. Healthy volunteers aged 20 to 45 years.
  2. Hypnotisability above 14 as measured by the Tellegan absorption scale.

Exclusion Criteria:

  1. Psychiatric diagnosis in axis I or axis II;
  2. Documented history of head injury or seizure disorder;
  3. Evidence of a disorder which could affect peripheral and central conduction such as multiple sclerosis, motor neuron disease, carpal tunnel syndrome, cervical spondylosis, diabetic neuropathy.
  4. Any other contraindication to TMS as specified in the safety guidelines for rTMS (Wassermann, 1998) such as cardiac pacemakers or metallic deep brain electrodes.
  5. Chronic pharmacological treatment.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00416247


Locations
Israel
Rambam Medical Center
Haifa, Israel, 31096
Sponsors and Collaborators
Rambam Health Care Campus
Investigators
Principal Investigator: Ehud Klein, MD Rambam Health Care Campus
  More Information

Responsible Party: Ehud Klein, MD, Head Department of Psychiatry, Rambam Medical Center
ClinicalTrials.gov Identifier: NCT00416247     History of Changes
Other Study ID Numbers: rambam2409_CTIL
First Submitted: December 26, 2006
First Posted: December 27, 2006
Last Update Posted: August 5, 2010
Last Verified: December 2006

Keywords provided by Rambam Health Care Campus:
Hypnosis
TMS
Cortical excitability